Flyer

www.mt.fh-jena.de

Department of Medical Engineering and Biotechnology

www.fh-jena.de

M. S

c.

Phar

mac

eutic

al

Bio

tech

nolo

gy

www.mt.fh-jena.de

Campus der EAH JenaCarl-Zeiss-Promenade 2

Road and rail links

Campus map

As o

f: Oc

tobe

r 201

4

1 Building 1 6 Refectory2 Building 2 7 Carl Zeiss Jena GmbH3 Building 3 8 Halls of residence4 Building 4 9 University sports centre5 Building 5

Dean's office Phone: +49 (0)3641 205-600, Fax: +49 (0)3641 205-601Email: [email protected]

Specialist course advi-sor

Prof. Christina SchumannPhone: +49 (0)3641 [email protected]

ntac

t

Graduation

Successful completion means graduates are awarded the internationally recognised academic degree Master of Science (M. Sc.) from the Ernst Abbe University of Applied Sciences.

Entrance Requirements

The accredited Master's course is open to graduates of the Biotechnology Bachelor's course as well as to graduates of related Bachelor's courses. A specified selection process is used for decisions about admissions onto the course.

Career Prospects

Pharmaceutical Biotechnology is currently enjoying the greates groth rate in the biotechnology sector. The transfer of findings from fundamental, modern cell and molecular-biological research to innovative pharmaceutical products for diagnosis and therapy of illnesses such as cancer, cardiovascular diseases, diabetes and illnesses of the immune system, offer high growth and employment opportunities in Germany, particularly in consideration of demographic developments in Western industrial nations.

The Master's degree enables graduates to work in the civil service for a career on higher management level and also the opportunity to study for a PhD (mainly research-centric course).

Master's Degree Course

Pharmaceutical Biotechnology

All information can be subject to additional change. No legally binding claims can be inferred from this informational flyer.

Carl-Zeiss-Promenade 2, Postfach 10 03 14, 07703 Jena, Germany

Successfully accredited by ACQUIN

Phot

os: E

AH J

ena,

S. R

eute

r

1st SemesterLow-molecule

Pharmaceutical Agents Bioprocess

Development

GMP/ Approval Procedures Genetic

EngineeringMolecular Cell

BiologyProtein

Engineering

Enzyme TechnologyMolecular Medicine

2nd Semester Biophysics 2 Bio-VT / ModellingRecombinant

ProductsProtein

Analysis

3rd Semester Elective Module Elective Module Molecular Test Systems Bioprocess ControlApplied

Pharmacology / Toxicology

Bioinstruments

4th Semester Master Thesis and Colloquium

An up-to-date list is created for the elective modules on a semester by semester basis.

Elective Module (example) Proteomics Molecular Tools Bioethics Medical Imaging

The curriculum has a modular format. For every successfully completed module, students are awarded a specified number of credit points in accordance with the European Credit Transfer System (ECTS). This system simplifies the recognition of course achievement when students switch to universities at home or abroad.

regulation of metabolism processes and their pathological changes in the development of illnesses, and to use this knowledge in the development and production of pharmaceuticals oriented towards human application. Graduates are able to carry out research and development work and research-intensive services on a biochemical and molecular cytological and instrumentation-related level.

They contribute greatly towards the development and production of:

a.) Therapeutic agents made of low-molecular and recombinant bioproducts

b.) Diagnostic agents with biochemical and molecular cell biological basis

c.) Analytical biochemical and molecular cytological R&D tools

Course Overview

The normal duration of the Pharmaceutical Biotechnology Master's course is four semesters. The Master's degree provides first and foremost subject-specific specialisation in the fields of recombinant and low-molecular bioproducts, bioprocess engineering, molecular biology and cell biology, enzyme technology, molecular medicine, genetic engineering and protein engineering. The 3rd semester of the curriculum includes two elective modules each carrying six ECTS credits. The elective modules enable students to study in greater depth subjects catching their interest and in line with their preferred areas of work in the future.The Master's thesis must be completed by students in the last semester. Scientific mentoring is provided by the relevant institution or university.

Course Contents and Objectives

The biotechnological application in the field of human medicine represents the content of the Pharmaceutical Biotechnology Master's course. Graduates are able to understand the molecular and cellular mechanisms of the regulation of metabolism processes and their pathological changes in the development of illnesses, and to use this knowledge in the development and production of pharmaceuticals oriented towards human application.

The Pharmaceutical Biotechnology course is currently the only course of its kind in Central Germany. The specific profile of the Master's course is derived from the clear-cut focus on biotechnological applications in the field of human medicine. This subarea of biotechnology is covered over its entire breadth - from the molecular target to sellable biotechnologically produced pharmaceutical products. In contrast to classic biotechnology, with strong instrumentation and process characterisation, students are taught specialised knowledge essential for understanding the development of illnesses and the effect mechanisms of pharmaceutical products. The course differs from "molecular-biochemical only" tuition courses in that it has strict orientation towards the development of new products and services.

Employment Opportunities

The Pharmaceutical Biotechnology course has a clear focus on biotechnological applications in the field of human medicine. Graduates are able to understand the molecular and cellular mechanisms of the